Abstract
In the present study solid dispersions of Raloxifene HCl were prepared by melt mixing. As drug carriers, biodegradable/ biocompatible aliphatic polyesters were used. These formulations were compared to those based on extensively used drug carriers such as PEG and Gelucire 50/13. The used aliphatic polyesters namely poly(propylene succinate) (PPSu) and poly(propylene adipate) (PPAd) were prepared by melt polycondensation. The polyesters have melting points close to human body temperature and were used for first time as drug carries. Polymer cytocompatibility based on HUVEC cells viability in the presence of increasing concentrations of polymer was investigated and it was found that PPSu and PPAd exhibit comparable cytocompatibility with poly(dl-lactide). The physical state of solid dispersions was evaluated by FTIR, SEM and XRD techniques. In all cases the interactions between drug and carriers are limited and thus the dispersed drug was mainly in the crystalline state. SEM revealed that the particles size of the dispersed drug increases with increasing the drug amount. The release behavior of the drug is affected from both the drug amount and the kind of the used carrier. The drug is released almost immediately from PEG formulations while Gelucire results in sustained release. In formulations that polyesters were used as drug carriers the release is slower.
Keywords: Raloxifene HCl, aliphatic polyesters, biocompatible polymers, PEG, Gelucire, melt mixing
Current Drug Delivery
Title: Effectiveness of Various Drug Carriers in Controlled Release Formulations of Raloxifene HCl Prepared by Melt Mixing
Volume: 6 Issue: 5
Author(s): Dimitrios Bikiaris, Vassilios Karavelidis and Evangelos Karavas
Affiliation:
Keywords: Raloxifene HCl, aliphatic polyesters, biocompatible polymers, PEG, Gelucire, melt mixing
Abstract: In the present study solid dispersions of Raloxifene HCl were prepared by melt mixing. As drug carriers, biodegradable/ biocompatible aliphatic polyesters were used. These formulations were compared to those based on extensively used drug carriers such as PEG and Gelucire 50/13. The used aliphatic polyesters namely poly(propylene succinate) (PPSu) and poly(propylene adipate) (PPAd) were prepared by melt polycondensation. The polyesters have melting points close to human body temperature and were used for first time as drug carries. Polymer cytocompatibility based on HUVEC cells viability in the presence of increasing concentrations of polymer was investigated and it was found that PPSu and PPAd exhibit comparable cytocompatibility with poly(dl-lactide). The physical state of solid dispersions was evaluated by FTIR, SEM and XRD techniques. In all cases the interactions between drug and carriers are limited and thus the dispersed drug was mainly in the crystalline state. SEM revealed that the particles size of the dispersed drug increases with increasing the drug amount. The release behavior of the drug is affected from both the drug amount and the kind of the used carrier. The drug is released almost immediately from PEG formulations while Gelucire results in sustained release. In formulations that polyesters were used as drug carriers the release is slower.
Export Options
About this article
Cite this article as:
Bikiaris Dimitrios, Karavelidis Vassilios and Karavas Evangelos, Effectiveness of Various Drug Carriers in Controlled Release Formulations of Raloxifene HCl Prepared by Melt Mixing, Current Drug Delivery 2009; 6 (5) . https://dx.doi.org/10.2174/156720109789941632
DOI https://dx.doi.org/10.2174/156720109789941632 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers